Nisa Investment Advisors’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.7K | Sell |
2,676
-686
| -20% | -$9.16K | ﹤0.01% | 1685 |
|
|
2025
Q1 | $34.3K | Buy |
3,362
+3,192
| +1,878% | +$32.5K | ﹤0.01% | 1701 |
|
|
2024
Q4 | $2.69K | Buy |
170
+84
| +98% | +$1.33K | ﹤0.01% | 2404 |
|
|
2024
Q3 | $4.99K | Buy |
86
+24
| +39% | +$1.39K | ﹤0.01% | 2228 |
|
|
2024
Q2 | $2.83K | Buy |
62
+21
| +51% | +$960 | ﹤0.01% | 2337 |
|
|
2024
Q1 | $2.71K | Buy |
41
+21
| +105% | +$1.39K | ﹤0.01% | 2187 |
|
|
2023
Q4 | $795 | Hold |
20
| – | – | ﹤0.01% | 2304 |
|
|
2023
Q3 | $638 | Buy |
20
+5
| +33% | +$160 | ﹤0.01% | 2478 |
|
|
2023
Q2 | $603 | Sell |
15
-380
| -96% | -$15.3K | ﹤0.01% | 2525 |
|
|
2023
Q1 | $17K | Buy |
395
+380
| +2,533% | +$16.4K | ﹤0.01% | 2056 |
|
|
2022
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 2459 |
|
|
2022
Q3 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 2456 |
|
|
2022
Q2 | – | Sell |
-860
| Closed | -$47K | – | 2445 |
|
|
2022
Q1 | $47K | Hold |
860
| – | – | ﹤0.01% | 1864 |
|
|
2021
Q4 | $40K | Buy |
+860
| New | +$40K | ﹤0.01% | 1786 |
|
|
2020
Q4 | – | Sell |
-1,515
| Closed | -$58K | – | 2313 |
|
|
2020
Q3 | $58K | Buy |
+1,515
| New | +$58K | ﹤0.01% | 1742 |
|